Literature DB >> 7200458

Kawasaki syndrome: an update.

M E Melish, R V Hicks, V Reddy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7200458     DOI: 10.1080/21548331.1982.11702289

Source DB:  PubMed          Journal:  Hosp Pract (Hosp Ed)        ISSN: 8755-4542


× No keyword cloud information.
  7 in total

1.  Acute severe hepatitis with coagulopathy: An unusual presentation of Kawasaki syndrome in association with Epstein-Barr virus.

Authors:  M M Gordon; E D Silverman; J H Kim; A M Huber; K Furuya
Journal:  Paediatr Child Health       Date:  2001-11       Impact factor: 2.253

2.  Kawasaki syndrome in office pediatrics.

Authors:  M T Stein
Journal:  West J Med       Date:  1984-10

3.  An unusual systemic staphylococcal illness with features of the mucocutaneous lymph node syndrome.

Authors:  K S Servilla; J A Green; H J Williams; J J Zone
Journal:  West J Med       Date:  1985-02

4.  Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii.

Authors:  Robert C Holman; Krista Y Christensen; Ermias D Belay; Claudia A Steiner; Paul V Effler; Jill Miyamura; Susan Forbes; Lawrence B Schonberger; Marian Melish
Journal:  Hawaii Med J       Date:  2010-08

5.  Cytopathogenic protein in filtrates from cultures of Propionibacterium acnes isolated from patients with Kawasaki disease.

Authors:  S Tomita; H Kato; T Fujimoto; O Inoue; Y Koga; N Kuriya
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-14

6.  Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease.

Authors:  Chih-Jen Chen; Fu-Chen Huang; Mao-Meng Tiao; Ying-Hsien Huang; Li-Yan Lin; Hong-Ren Yu; Kuender D Yang; Yi-Chuan Huang; Chih-Cheng Chen; Wei-Chiao Chang; Ho-Chang Kuo
Journal:  ScientificWorldJournal       Date:  2012-06-18

7.  Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.

Authors:  Karl Migally; Elizabeth A Braunlin; Lei Zhang; Bryce A Binstadt
Journal:  Pediatr Res       Date:  2018-05-02       Impact factor: 3.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.